{"id":"W2047170994","doi":"10.1016/j.neurobiolaging.2012.03.006","title":"Estimating sample sizes for predementia Alzheimer's trials based on the Alzheimer's Disease Neuroimaging Initiative","year":2012,"lang":"en","type":"article","venue":"Neurobiology of Aging","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"National Institute of General Medical Sciences; National Institute on Aging; University of California, Los Angeles; Canadian Institutes of Health Research; Genentech; National Institutes of Health; Servier; Eisai; Northern California Institute for Research and Education; University of California, San Diego; Pfizer; Biogen; BioClinica; Alzheimer's Association; Amorfix Life Sciences; F. Hoffmann-La Roche; Medpace; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Bayer HealthCare; Meso Scale Diagnostics; Alzheimer's Disease Neuroimaging Initiative; Novartis Pharmaceuticals Corporation; Synarc","keywords":"Clinical Dementia Rating; Dementia; Neuroimaging; Alzheimer's disease; Alzheimer's Disease Neuroimaging Initiative; Population; Psychology; Biomarker; Rating scale; Disease; Clinical trial; Sample size determination; Cognition; Cognitive decline; Audiology; Clinical psychology; Psychiatry; Medicine; Internal medicine; Developmental psychology; Biology; Genetics","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.3237062,0.001680499,0.006471517,0.002268839,0.0008990732,0.002842853,0.003960537,0.004757315,0.002827819],"category_scores_gemma":[0.5004996,0.001531988,0.007603545,0.001652939,0.003572454,0.004063988,0.003536663,0.00611474,0.0003243793],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00128534,"about_ca_system_score_gemma":0.001534067,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001807877,"about_ca_topic_score_gemma":0.001806686,"domain_scores_codex":[0.663192,0.3073458,0.01349493,0.009346883,0.005280926,0.0013394],"domain_scores_gemma":[0.4377687,0.5299485,0.01073143,0.01635296,0.003643689,0.001554793],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.1722601,0.001592384,0.3282881,0.008806108,0.1127927,0.001537143,0.003544108,0.04286202,0.003208861,0.04461878,0.01895157,0.2615382],"study_design_scores_gemma":[0.1309613,0.0304981,0.2234007,0.003032897,0.09191994,0.003220206,0.001674027,0.2945582,0.007097381,0.1828427,0.03018124,0.0006133057],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.5873108,0.03881951,0.3218772,0.01104113,0.004641488,0.02021191,0.00400489,0.0008018438,0.01129114],"genre_scores_gemma":[0.9312347,0.001252777,0.0547276,0.001657447,0.00036665,0.008693345,0.001271961,0.00007123319,0.0007242415],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3237062,"threshold_uncertainty_score":0.8339907,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1361356262326201,"score_gpt":0.3888516976460014,"score_spread":0.2527160714133814,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}